Apply Now

Tuesday, 12 November 2013
For the latest program information, visit http://cosa2013.mobile.asnevents.com.au on your smart
phone or laptop.
Breakfast Sessions
COSA Breakfast Session: e-tools for geriatric assessment with Janine Overcash
7:00 AM - 8:20 AM
Meeting Room 1&2
Sponsor Breakfast Symposium: Cancer pain management guidelines
7:00 AM - 8:20 AM
Hall D
Sponsor Breakfast Symposium: Oral chemotherapy: Improving quality of life for advanced
breast cancer patients
7:00 AM - 8:20 AM
Meeting Room 10&11
The conference acknowledges the sponsorship of
Official Welcome and Opening
8:30 AM - 9:00 AM
Hall E
Chair: COSA President, Sandro V Porceddu
- Welcome to the Country
- Official Opening, His Excellency Rear Admiral Kevin Scarce AC CSR RANR, Governor of South
Australia
Plenary
The burden of cancer in the elderly
9:00 AM - 10:30 AM
Chair: Robert Prowse
Panel Facilitator: Dorothy Keefe
9:00 AM
9:25 AM
9:50 AM
10:15 AM
The conference acknowledges the sponsorship of
David Roder
Meeting the challenges of cancer in the elderly abs# 1
Harvey Cohen
Geriatric oncology – What is it and why do we need it? abs# 2
John Hill
Economic challenges to manage health with aging population abs# 3
Panel Discussion
Hall E
Morning tea and Poster viewing
10:30 AM - 11:00 AM
Exhibition Hall H
The conference acknowledges the sponsorship of
Concurrent Symposia
Practice pearls: What is different when dealing with the older patient
11:00 AM - 12:30 PM
Chair: Jon Hogan Doran
Hall E
The conference acknowledges the sponsorship of
11:00 AM
11:15 AM
11:30 AM
11:45 AM
12:00 PM
Glyn Jamieson
Operating on the older patient with cancer abs# 4
Christopher Steer
What is different when dealing with the older patient? A medical oncologist’s perspective
abs# 5
Janine Overcash
What is different about looking after older adults with cancer? The nurses' perspective abs#
6
Elizabeth Isenring
Nutrition in the older cancer patient - practical tips for screening, assessment and
intervention abs# 7
Discussion
Exercise and cancer
11:00 AM - 12:30 PM
Hall C
Chair: James Dollman
11:00 AM
Robert Newton
Pre-surgical exercise prescription for cancer patients abs# 8
11:20 AM
Lee Jones
Cancer as a model of accelerated physiological aging and mitigating effect of exercise
training abs# 9
11:50 AM
Daniel Galvao
Exercise and genitourinary cancer survivorship abs# 10
12:10 PM
Sandi Hayes
Translating evidence into practice: incorporating exercise into standard cancer care abs# 11
How do we support the delivery of quality cancer care? Building bridges between coal face
delivery, service providers, management and government
11:00 AM - 12:30 PM
Hall D
This integrated session will present different perspectives on what the delivery of quality cancer care
means and how we can overcome the challenges we face in delivering continuous quality improvement.
Perspectives will include medical and nursing practitioners as well as cancer managers and government
agencies. This session builds on the very well received quality breakfast session at COSA last year. The
session will conclude with a panel discussion on how we deliver quality care and how COSA can support
this.
Chair: Guy Maddern
Speakers: Thomas Aloia, Jeff Bull, Dorothy Keefe, Ben Stevenson, Heather Buchan
Panel Chair: Tim Shaw
Panel discussants: Heather Buchan, Jeff Bull, Bogda Koczwara, Guy Maddern, Sue Sinclair, Ben Stevenson
Private Symposium: Cancer 2015 – Cross-disciplinary research of a genomic cancer cohort
11:00 AM - 12:30 PM
Chair: John Parisot
11:00 AM
John Parisot
Introduction abs# 12
11:10 AM
Paul James
Genome defined cancer risk. abs# 13
11:30 AM
Stephen Fox
Early molecular pathology insights abs# 14
11:50 PM
Paula Lorgelly
Health economic perspective on cancer care abs# 15
12:10 PM
Richard Sullivan
Global perspectives on genomic cohorts abs# 16
Meeting Room 1&2
Best of the Best Orals: Basic and Translational
11:00 AM - 12:30 PM
Meeting Room 10&11
Chair: John Zalcberg
Discussant: Bas Wijnhoven
11:00 AM
Fran Boyle
Clinical practice guidelines for the management of central nervous system metastases in
women with secondary breast cancer abs# 17
11:15 AM
Victoria Gray
Development and early outcomes of the find cancer early community education campaign in
regional Western Australia abs# 18
11:30 AM
Judy Kirk
Clinical practice guidelines for the management of breast cancer in women with an identified
BRCA1 or BRCA2 gene mutation or at high risk of a gene mutation abs# 19
11:45 AM
Bronwen Mayo
The effect of the new selective GLP-2 Agonist, Elsiglutide, on Irinotecan-Induced diarrhoea
and mucositis in the rat abs# 20
12:00 PM
Fiona Young
The Biology of fertility loss in oncology patients and advances in fertility preservation
strategies abs# 21
Lunch
12:30 PM - 1:30 PM
Exhibition Hall H
Lunchtime Meetings
COSA Psycho-oncology Group AGM (Hall C)
COSA Cancer Pharmacists Group AGM (Hall D)
COSA Clinical Trials and Research Professionals Group AGM (M1&2)
COSA Familial Cancer Group AGM (M10&11)
Plenary
Evidence based cancer management in older patients
1:30 PM - 3:00 PM
Co-Chairs: Sid Silva and Ken Pittman
1:30 PM
Christopher Steer
Ovarian cancer in the elderly - the role of surgery and systemic treatment abs# 22
1:50 PM
Mark Hertzberg
Treatment of lymphomas in patients over 65 yrs of age abs# 23
2:10 PM
Elizabeth Hovey
Elderly patients and glioma - navigating the gaps in the evidence abs# 24
2:30 PM
Harvey Cohen
Anemia in the elderly: New wrinkles on an old problem abs# 25
Hall E
Afternoon tea, Best of the Best Posters and Poster viewing
3:00 PM - 4:00 PM
Exhibition Hall H
The conference acknowledges the sponsorship of
Posters (See listing following Program) –
Basic and Translational - numbers 161 - 165
l
Clinical research - numbers 166 - 196
Education - numbers 197 - 202
Health services - numbers 203 - 243
Best of the Best Posters: Health services
3:15 PM - 4:00 PM
Theatrette 1 in Exhibition Hall H
Chair: Bruce Mann
Discussant: Gillian Mitchell (tbc)
3:15 PM
Jessica Abbott
Validating a novel, low cost, automated malnutrition screening system as a predictor of
nutritional risk in the oncology day care unit abs# 141
3:20 PM
Bridie Thompson
Cost-Savings for laparoscopic resection compared with open resection for colorectal cancer in
a region of high uptake abs# 142
3:25 PM
Deme Karikios
The rising cost of anti-cancer drugs in Australia abs# 143
3:30 PM
Annette Tognela
Patterns of care in elderly patients with resected non-small cell lung cancer (NSCLC) in South
Western Sydney local health district (SWSLHD) abs# 144
3:35 PM
Agnes Vitry
Use and cost of chemotherapy in Australia between 2000 and 2011 abs# 145
Best of the Best Posters: Researching cancer treatments
3:15 PM - 4:00 PM
Theatrette 2 in Exhibition Hall H
Chair: Ian Davis
Discussant: David Goldstein
3:15 PM
Daniel Brungs
Evidence confirming intermittent androgen deprivation as rational standard-of-care treatment
for metastatic prostate cancer: A meta-analysis of pooled data from 5405 patients with fixed
effect modelling abs# 146
3:20 PM
Donna Gillies
Pancreatico-duodenectomy with high quality results in a medium volume centre. What are
the Australian definitions of low volume abs# 147
3:25 PM
Yaping Liu
How is cancer research reported by the cancer council’s cancer daily news abs# 148
3:30 PM
Vinayak Nagaraja
Safety and efficacy of esophageal stents preceding or during neoadjuvant chemotherapy for
esophageal cancer: A systematic review and meta-analysis abs# 149
3:35 PM
Dannie Zarate
Colorectal cancer surgery rates in indigenous versus nonindigenous patients abs# 150
Concurrent Symposia
Medicine matters in the older cancer patient
4:00 PM - 5:30 PM
Chair: Ben Stevenson
4:00 PM
4:25 PM
4:50 PM
Hall E
The conference acknowledges the sponsorship of
Christine Carrington
Medication adherence abs# 26
Jenny Casanova
Medicine(s) matter(s) in the older patient: Understanding, counselling and health literacy
abs# 27
Alexandre Chan
Medicine matters in the older cancer patient: Drug interactions and toxicities abs# 28
Where to care?
4:00 PM - 5:30 PM
Hall C
Chair: Marion Eckert
4:00 PM
Janine Overcash
Healthcare needs of the senior adult who lives in urban versus rural communities abs# 29
4:20 PM
Christine Drummond
Is ICU an appropriate place for elderly cancer patients? abs# 30
4:40 PM
Natasha Michael
Dying at home abs# 31
5:00 PM
Meera Agar
Care for people living with cancer in residential aged care abs# 32
Private Symposium – Advances in nutrition and cancer
4:00 PM - 5:30 PM
Hall D
Chair: Judy Bauer
4:00 PM
Judy Bauer
Introduction abs# 33
4:15 PM
Merran Findlay
Maintaining evidence-based guidelines online: update on nutritional management of patients
with head and neck cancer abs# 34
4:30 PM
Wolfgang Marx
Chemotherapy-induced nausea and vomiting: A review to inform clinical practice abs# 35
4:45 PM
Elizabeth Isenring
Overview of evidence-based practice guidelines for the nutritional management of patients
receiving anticancer therapy abs# 36
5:00 PM
Judy Bauer
Nutritional management of patients with asbestos related diseases abs# 37
5:15 PM
Discussion
Private Symposium – Managing the knowledge base for oncology
4:00 PM - 5:30 PM
Chair: Jennifer Tieman
4:00 PM
Jennifer Tieman
Introduction abs# 38
4:20 PM
Jennifer Tieman
Effective searching: Evidence based solutions abs# 39
4:40 PM
Jutta von Dincklage
Developing wiki-based clinical practice guidelines for cancer abs# 40
5:10 PM
Catherine Johnson
Sustaining the currency of the evidence base of eviQ abs# 41
Meeting Room 1&2
Best of the Best Orals: Gastro-intestinal cancers
4:00 PM - 5:30 PM
Meeting Room 10&11
Chair: Eva Segelov (tbc)
Discussant: Rebecca Wong (tbc)
4:00 PM
Amber Kelaart
Development and implementation of evidence-based nutrition care pathways for upper
gastrointestinal oncology patients abs# 42
4:15 PM
Muhammad Khattak
Prognostic value of systemic inflammation-based neutrophil-lymphocyte ratio, plateletlymphocyte ratio and modified glasgow prognostic score in advanced pancreatic cancer abs#
43
4:30 PM
Tim Price
ASPECCT: A randomised, multicentre, open-label, phase 3 study of Panitumumab vs
Cetuximab for previously-treated wild-type (WT) KRAS metastatic colorectal cancer (mCRC)
abs# 44
4:45 PM
June Savva
Exploring potential benefit of earlier nutritional interventions in adults with upper
gastrointestinal cancer: a randomised trial abs# 45
5:00 PM
Joanne Shaw
Family CONNECT: A randomised controlled trial to improve psychosocial outcomes for cancer
carers abs# 46
5:15 PM
Virginia Signal
Ethnic inequalities in stomach cancer treatment pathways abs# 47
Best of the Best Orals: Clinical research
4:00 PM - 5:30 PM
Meeting Room 5
Chair: Alan Coates
Discussant: Vanessa Blair
4:00 PM
Robert Andtbacka
OPTiM: a randomised phase 3 trial of talimogene laherparepvec (T-VEC) vs subcutaneous (SC)
granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment of unresected
stage IIIB/C and IV melanoma abs# 48
4:15 PM
Belinda Kiely
Prognostic significance, accuracy and usefulness of oncologists estimates of survival time for
patients starting first line chemotherapy for advanced non-small cell lung cancer (ANSCLC)
abs# 49
4:30 PM
James Kuo
Treatment outcomes of rapid desensitisation protocols for chemotherapeutic agents and
monoclonal antibodies following hypersensitivity reactions abs# 50
4:45 PM
Anthony Linton
5:00 PM
5:15 PM
Disease and patient characteristics related to survival in a large population-based cohort of
patients with Malignant Pleural Mesothelioma (MPM) abs# 51
Megan Lyle
Somatic mutations in metastatic melanoma in a large cohort of Australian patients abs# 52
Dirkje Sommeijer
Prognostic value of early objective tumor response (eotr) to first line systemic therapy in
Metastatic Colorectal Cancer (Mcrc): Individual Patient Data (IPD) meta-analysis of
randomized trials from the ARCAD database abs# 53
Welcome Function and Luminous Awards
5:30 PM - 7:00 PM
Exhibition Hall (H)
The conference acknowledges the sponsorship of
The Luminous Awards will be presented from 5:50pm in Theatrette 1 within Hall H
Sponsor Dinner Symposium: Immunotherapy in melanoma - a new age of immune activation
7:00 PM - 9:30 PM
Meeting Room 10&11
The conference acknowledges the sponsorship of
Sponsor Dinner Symposium: Changing paradigms in advanced prostate cancer
7:00 PM – 9:30 PM
Meeting Room 1&2
The conference acknowledges the sponsorship of
Sponsor Dinner Symposium: Advanced energy
7:00 PM – 9:30 PM
Hall D
The conference acknowledges the sponsorship of
Wednesday, 13 November 2013
For the latest program information, visit http://cosa2013.mobile.asnevents.com.au on your smart
phone or laptop.
Breakfast Sessions
COSA Breakfast Session: Guidelines on pre-exercise screening and exercise prescription in
the oncology setting workshop with Lee Jones
7:00 AM - 8:45 AM
Hall D
Sponsor Breakfast Symposium: Handling hazardous drugs, safety with savings
7:00 AM - 8:45 AM
Meeting Room 10&11
The conference acknowledges the sponsorship of
Sponsor Breakfast Symposium: "VOYCE" breakfast meeting
7:00 AM - 8:45 AM
Meeting Room 1&2
The conference acknowledges the sponsorship of
Plenary
The changing face of oesophageal cancer: Moving towards individualised care
9:00 AM - 10:30 AM
Hall E
The conference acknowledges the sponsorship of
Chair: Sarah Thompson
9:00 AM
Bas Wijnhoven
Beyond routine staging investigations, how to choose the right patients for oesophagectomy?
abs# 54
9:20 AM
Rebecca Wong
The role of definitive chemoradiotherapy – how to avoid the knife abs# 55
9:40 AM
Ian Chau
What is the optimal neoadjuvant chemotherapy regimen in resectable oesophageal cancer?
abs# 56
10:00 AM
Jon Shenfine
At what age is multimodal therapy and surgery no longer affordable? abs# 57
10:20 AM
Discussion
Morning tea and Poster viewing
10:30 AM - 11:00 AM
Exhibition Hall H
The conference acknowledges the sponsorship of
Concurrent Symposia
Recent advances in the management of upper gastro-intestinal cancer treatment
11:00 AM - 12:30 PM
Hall E
The conference acknowledges the sponsorship of
Chair: David Watson
11:00 AM
Rajvinder Singh
Endoscopic diagnosis and treatment of dysplasia and early cancer in the Upper GIT abs# 58
11:20 AM
Ian Chau
Targeted therapy in oesophago-gastric cancer abs# 59
11:40 AM
Rebecca Young
Opportunities with Stereotactic Radiotherapy in Upper GI Cancer abs# 60
12:00 PM
Bas Wijnhoven
Operative and Non-Operative Management of Locally Advanced Oesophageal Cancer abs# 61
12:20 PM
Discussion
Cognition: Ageing and treatment
11:00 AM - 12:30 PM
Hall C
The conference acknowledges the sponsorship of
Chair: Haryana Dhillon
11:00 AM
Janette Vardy
Cognition after chemotherapy: An overview abs# 62
11:20 AM
Alexandre Chan
Chemotherapy-induced cognitive impairment: Cultural considerations abs# 63
11:40 AM
Heather Green
Cognitive rehabilitation interventions abs# 64
11:55 AM
Ian Johnston
Assessing mechanisms of cognitive impairment from chemotherapy using rat models abs# 65
12:10 PM
Haryana Dhillon
Cognition after Chemotherapy: anti-treatment in an aging population abs# 66
Familial gastric cancer: Management challenges
11:00 AM - 12:30 PM
Hall D
The conference acknowledges the sponsorship of
Chair: Nicola Poplawski
11:00 AM
Lara Lipton
Familial intestinal type gastric cancer: Which genes? What surveillance? abs# 67
11:20 AM
Vanessa Blair
Hereditary Diffuse Gastric Cancer – Surveillance or Prophylactic Gastrectomy abs# 68
11:40 AM
Graeme Suthers
Familial Gastric Polyposis and Adenocarcinom abs# 69
12:00 PM
Louise Mudge
Can I live without my stomach: long-term dietary challenges abs# 70
Best of the Best Orals: Epidemiology
11:00 AM - 12:30 PM
Meeting Room 1&2
Chair: (tbc)
Discussant: Dirk Arnold
11:00 AM
Satyamurthy Anuradha
Survival of Australian women with Epithelial Ovarian Cancer – a population-based study abs#
71
11:15 AM
Carole Harris
HER2 Positive Early Breast Cancer (HER2EBC): An Australian pattern of care study abs# 72
11:30 AM
Andrea McDonald
Casting a long shadow: the role of household crowding on Helicobacter pylori infection, and
excess stomach cancer incidence among Maori and Pacific people in New Zealand abs# 73
11:45 AM
Georgina Prassas
Patterns of Breast Cancer Care in Victoria: A joint Breast Cancer Quality Project abs# 74
12:00 PM
Matthew Soeberg
Trends in ethnic and socioeconomic inequalities in cancer survival, New Zealand, 1991-2004
abs# 75
12:15 PM
Patricia Valery
Childhood cancer in indigenous populations worldwide: A systematic review abs# 76
Best of the Best Orals: Education
11:00 AM - 12:30 PM
Meeting Room 10&11
Chair: Meinir Krishnasamy
Discussant: Paul Katris
11:00 AM
Alana Fisher
The effect of biased health information and consumer attitudes on anticipated whole genome
screening uptake abs# 77
11:15 AM
Yeh Chen Lee
Information seeking behaviours of patients with cancer abs# 78
11:30 AM
Belinda Morris
A collaborative approach - the next steps: Delivering state-wide cancer pharmacy training
abs# 79
11:45 AM
Jane Phillips
Impact of a Qstream Online Learning Module on palliative care nurses’ pain assessment
competencies and patients’ reports of pain: results from a quasi-experimental pilot study
abs# 80
12:00 PM
Gail Rowan
12:15 PM
A self-directed e-learning package for pharmacists involved in the dispensing and checking of
oral anti-cancer therapies abs# 81
Sue Sinclair
The impact of Fear of Cancer Recurrence on wellness abs# 82
Lunch
12:30 PM - 1:30 PM
Exhibition Hall H
Lunchtime Meetings
COSA members AGM (Hall C - lunches available at the room)
Plenary
Managing hepatobillary and pancreatic cancers: Challenging cases
1:30 PM - 3:00 PM
Hall E
The conference acknowledges the sponsorship of
This sessions follows a highly successful format used at previous meetings. It is designed to provide a
forum for discussion of the complex issues which arise in the care of patients with hepatobiliary and
pancreatic cancers. The facilitator will present a series of challenging clinical cases and engage members
of the multidisciplinary panel in discussion. There will also be opportunities for members of the audience
to contribute to the discussion.
Chair: Robert Padbury
Facilitator: John Chen
Panel: Thomas Aloia, Patricia Ganz, David Goldstein, Mark Lee, Dan Madigan, Jane Phillips
Afternoon tea, Best of the Best Posters and Poster viewing
3:00 PM - 4:00 PM
Exhibition Hall H
The conference acknowledges the sponsorship of
Posters (See listing following Program) –
Epidemiology - numbers 251 - 265
Supportive care - numbers 266 - 300
Gastro-intestinal cancers - numbers 301 - 313
Geriatric oncology - numbers 314 - 318
Service provision - numbers 319 - 327
Trials in progress - numbers 328 - 339
Best of the Best Posters: Supporting cancer patients
3:15 PM - 3:45 PM
Theatrette 1 in Exhibition Hall H
Chair: Patsy Yates
Discussant: Lee Jones
3:15 PM
Phyllis Butow
Caring for women with ovarian cancer in the last year of their life: Impact on the caregiver
abs# 151
3:20 PM
Laal Farrokhzadi
Physical activity predictors and preferences among gynaecological cancer survivors abs# 152
3:25 PM
Heather Lane
How are geriatric assessment domains and age discussed in cancer multidisciplinary meetings?
abs# 153
3:30 PM
Janelle Levesque
Do men with prostate cancer and their partners receive the information and support they
need for optimal illness self-management? abs# 154
Best of the Best Posters: Cancer side effects and symptoms
3:15 PM - 3:45 PM
Theatrette 2 in Exhibition Hall H
Chair: Christine Carrington
Discussant: Fran Boyle
3:15 PM
Vanessa Beesley
Pancreatic cancer patient’s moderate or high unmet supportive care needs over time and risk
factors of future unmet needs abs# 155
3:20 PM
Joanne Bowen
Immune genetic variability is associated with risk of severe gastrointestinal toxicity in
patients treated with Fluorouraci abs# 156
3:25 PM
Heather Heron-Speirs
Understanding the distress and coping of men with cancer indicates the integration of
comprehensive and accessible information into standard treatment paths abs# 157
3:30 PM
Victoria-Mae Rasmussen
Stress and burnout, work engagement and meaningful work in psychosocial health
professionals working in oncology abs# 158
3:35 PM
Patricia Valery
Traditional Indigenous medicine and complementary medicine use amongst Indigenous cancer
patients in Queensland, Australia abs# 159
Concurrent Sessions
Breast cancer and genetic testing - clinical practice points
4:00 PM - 5:30 PM
Hall E
Chair: Graeme Suthers
4:00 PM
Vanessa Blair
Lobular Breast Cancer and E-cadherin abs# 83
4:20 PM
Nicola Poplawski
Triple Negative Breast Cancer: Is it Genetic? abs# 84
4:30 PM
Mary-Anne Young
Risk reducing bilateral mastectomy for BRCA1/2 mutation carriers: body image and its impact
on the before and after abs# 85
4:50 PM
Gillian Mitchell
PARP inhibitors and familial breast cancer abs# 86
5:15 PM
Discussion
Fine wine: The old and the new in prostate cancer
4:00 PM - 5:30 PM
Hall C
The conference acknowledges the sponsorship of
Chair: Ian Davis
4:00 PM
Wayne Tilley
Androgens: role in aging & prostate cancer - non castrate and castrate resistant states abs#
87
4:15 PM
Nicholas Brooks
Radical prostatectomy vs surveillance: Does age matter? abs# 88
4:35 PM
Raghu Gowda
Fine wine: The old and the new in radiation therapy for prostate cancer abs# 89
4:55 PM
Alexandre Chan
Castrate-Resistant Prostate Cancer: New wine and its challenges abs# 90
Private Symposium: Outcomes versus access, who is most vulnerable? A ‘wicked’ issue for
cancer surgery in Australia
4:00 PM - 5:30 PM
Hall D
Chair: Bruce Barraclough
4:00 PM
Bruce Barraclough
Outcomes versus access: Who is most vulnerable? A ‘Wicked’ issue for cancer surgery in
Australia abs# 91
4:15 PM
Robert Tam
Patterns of cancer surgery in rural versus urban cancer patients abs# 92
4:30 PM
Mark Smithers
The volume-outcome relationship in cancer surgery - do rural patients have a choice? abs#
93
4:45 PM
Tony Green
Patterns of mastectomy for invasive breast cancer in Queensland abs# 94
5:00 PM
Andrew Johnson
Patient flows in cancer surgery abs# 95
Best of the Best Orals: Geriatric oncology
4:00 PM - 5:30 PM
Meeting Room 1&2
Chair: Christopher Steer
Discussant: Harvey Cohen
4:00 PM
Mary-Jane Courage
One age does not fit all: Geriatric cancer patients are not a single homogenous group abs#
96
4:15 PM
Mikaela Jorgensen
A mortality risk prediction tool for older adults with lymph node-positive colon cancer abs#
97
4:30 PM
Richard Khor
Patient selection for radiotherapy in the elderly population: The importance of performance
status abs# 98
4:45 PM
Raghav Murali-Ganesh
Exploring potential benefit of earlier nutritional interventions in adults with upper
gastrointestinal cancer: a randomised trial abs# 99
5:00 PM
Sagun Parakh
Patterns of care of elderly patients with metastatic colorectal cancer abs# 100
5:15 PM
Timothy To
Self-reported geriatric assessment predicts poor outcomes in elderly cancer patients abs#
101
Best of the Best Orals: Supportive care
4:00 PM - 5:30 PM
Meeting Room 10&11
Chair: Phyllis Butow
Discussant: Patricia Ganz
4:00 PM
Prue Cormie
Effectiveness of a community based exercise program for cancer survivors abs# 102
4:15 PM
Prue Cormie
Differential impact of aerobic fitness and muscular strength on bone health, body
composition, physical function and patient reported outcomes in men with prostate cancer
abs# 103
4:30 PM
Dorothy Keefe
Chemotherapy Induced Nausea and Vomiting (CINV) in the Asia-Pacific region ‘The Australian
Perspective from the Asian-Australasian Chemotherapy Induced Emesis Study’ (PrACTICE)
abs# 104
4:45 PM
Melanie Price
Psychosocial predictors of survival in women with invasive ovarian cancer: a population-based
prospective study abs# 105
5:00 PM
Dennis Taaffe
A multicenter year-long randomized controlled trial of exercise training targeting
cardiovascular risk factors and physical functioning in older men with prostate cancer abs#
106
5:15 PM
Janette Vardy
A longitudinal, prospective study evaluating fatigue and quality of life in colorectal cancer
(CRC) Patients abs# 107
Evening Meetings (5:30 PM - 6:30pm)
COSA
COSA
COSA
COSA
Complementary and Integrative Therapies Group AGM (Hall C)
Survivorship Group AGM (Hall D)
Urological Oncology Group AGM (M1&2)
Developing Nations Group AGM (M10&11)
COSA Conference Dinner
7:00 PM Pre - dinner Drinks
7:30 PM - late
Foyer F-G
Hall F
The conference acknowledges the sponsorship of
Includes the Tom Reeve Oration, delivered by Professor Ian Frazer AC
Thursday, 14 November 2013
For the latest program information, visit http://cosa2013.mobile.asnevents.com.au on your smart
phone or laptop.
Sponsor Breakfast Symposium: Optimising treatment for BRAF mutation positive metastatic
melanoma patients
7:00 AM - 8:45 AM
Meeting Room 1&2
The conference acknowledges the sponsorship of
Sponsor Breakfast Symposium: Implementation of the National Cancer Workforce Strategic
Framework (NCWSF)
7:00 AM - 8:30 AM
Meeting Room 10&11
The conference acknowledges the sponsorship of
Sponsor Breakfast Symposium: New treatment paradigms in the management of mCRC
7:00 AM - 8:45 AM
Hall D
The conference acknowledges the sponsorship of
Plenary
Conundrums in colorectal cancer
9:00 AM - 10:30 AM
Hall E
The conference acknowledges the sponsorship of
Chair: Chris Karapetis
9:00 AM
Dirk Arnold
Do we have to keep patients on treatment forever? When is it OK to stop? abs# 108
Dirk Arnold’s participation is assisted by an unrestricted grant from Roche
9:20 AM
Thomas Aloia
The Potential for Freedom from Adjuvant Chemotherapy: An Under-Recognized Benefit of
Surgical Therapy for Colorectal Liver Metastases abs# 109
9:40 AM
Sam Ngan
What is the optimal length of neo-adjuvant therapy? abs# 110
10:00 AM
Patricia Ganz
Cancer Survivorship Issues in Patients with Gastrointestinal Cancers abs# 111
Patricia Ganz’s participation is assisted by an unrestricted grant from
Flinders Medical Centre Foundation
Morning tea
10:30 AM - 11:00 AM
Exhibition Hall H
Concurrent Symposia
Let's talk about sex
11:00 AM - 12:30 PM
Hall E
Chair: Bogda Koczwara
11:00 AM
Kate White
Introduction to sexuality and cancer, psycho sexual issues and interventions abs# 112
11:20 AM
Addie Wootten
Male sexuality and cancer: The impact below the belt abs# 113
11:40 AM
Kim Hobbs
Assessing and responding to psychosexual concerns of older people with cancer abs# 114
12:00 PM
Patsy Yates
Developing health professional’s capabilities in the provision of psychosexual care abs# 115
Colorectal cancer in the elderly
11:00 AM - 12:30 PM
Hall C
The conference acknowledges the sponsorship of
Chair: Timothy Price
11:00 AM
Dirk Arnold
Do old patients need more holidays than younger patients? abs# 116
11:20 AM
Andrew Luck
The ageing population and its relevance to colorectal cancer surgery abs# 117
11:40 AM
Sam Ngan
Quality of life in patients with anorectal cancer treated with combined therapy abs# 118
12:00 PM
Jim Siderov
Toxicity of chemotherapy in elderly patients with colorectal cancer abs# 119
Palliative care - therapeutic interventions and models of care
11:00 AM - 12:30 PM
Chair: Timothy To
Discussant: Phyllis Butow
11:00 AM
Meera Agar
Recent developments in therapeutics and interventions in palliative care abs# 120
11:20 AM
Jane Phillips
Palliative Evidence for key models of care elements abs# 121
11:40 AM
Jennifer Tieman
Ehealth in palliative care abs# 122
12:00 PM
Deidre Morgan
The evidence base for rehabilitation in palliative care abs# 123
Hall D
Private Symposium: Cancer care in the context of comorbidity
11:00 AM - 12:30 PM
Meeting Room 1&2
Chair: Diana Sarfati
11:00 AM
Diana Sarfati
Introduction abs# 124
11:10 AM
Diana Safarti
How does cancer interact with comorbidity? abs# 125
11:25 AM
Jason Gurney
The prevalence and importance of comorbidity in cancer abs# 126
11:40 AM
Patricia Valery
A comparison between indigenous and non-indigenous Australians abs# 127
11:55 AM
Louise Signal
The role of comorbidity in cancer care decision-making in multidisciplinary teams abs# 128
12:10 PM
Inga O’Brien
Self-management of comorbidity and recovery after colorectal cancer: A phase I/II study
abs# 129
Best of the Best Orals: Health services
11:00 AM - 12:30 PM
Meeting Room 10&11
Chair: Matthew Links
Discussant: Ian Chau
11:00 AM
Mikaela Jorgensen
Should abdominoperineal resection rate be used as a surrogate marker of hospital quality in
rectal cancer surgery? abs# 130
11:15 AM
Muhammad Khattak
An observational study exploring the survival differences for advanced cancer patients
treated in metropolitan Perth compared to rural Western Australia (WA) abs# 131
11:30 AM
Danette Langbecker
Findings from a systematic review on cancer care coordinators abs# 132
11:45 AM
Andrea Schaffer
Health service use, treatment patterns, and survival for cancer of unknown primary: A data
linkage study abs# 133
12:00 PM
Lindy Masya
Quality of life and other patient reported outcomes following pelvic exenteration for pelvic
malignancy: prospective, comparative study abs# 134
Lunch
12:30 PM - 1:30 PM
Lunchtime Meetings
COSA Geriatric oncology Group AGM (MR 10&11)
Exhibition Hall H
Plenary:
COSA Presidential Lecture: Professor Ian Maddocks
1:30 PM - 2:30 PM
Chair: Sandro V Porceddu
Hall E
Hot Topic Debate
The older you are the less you get
2:30 PM - 3:45 PM
Moderator: Stephen Ackland
Panel: (tbc)
Hall E
Conference close
3:45 PM – 4:00 PM
Hall E
Poster Listings
For the latest program information, visit http://cosa2013.m.asnevents.com.au on your smart phone or
laptop.
Session 1 - Tuesday
Best of the Best Posters
Jessica Abbott
Validating a novel, low cost, automated malnutrition screening system as a predictor of nutritional risk in the oncology
day care unit abs# 141
Bridie Thompson
Cost-Savings for laparoscopic resection compared with open resection for colorectal cancer in a region of high uptake
abs# 142
Deme Karikios
The rising cost of anti-cancer drugs in Australia abs# 143
Annette Tognela
Patterns of care in elderly patients with resected non-small cell lung cancer (NSCLC) in South Western Sydney local
health district (SWSLHD) abs# 144
Agnes Vitry
Use and cost of chemotherapy in Australia between 2000 and 2011 abs# 145
Daniel Brungs
Evidence confirming intermittent androgen deprivation as rational standard-of-care treatment for metastatic prostate
cancer: A meta-analysis of pooled data from 5405 patients with fixed effect modelling abs# 146
Donna Gillies
Pancreatico-duodenectomy with high quality results in a medium volume centre. What are the Australian definitions
of low volume abs# 147
Yaping Liu
How is cancer research reported by the cancer council’s cancer daily news abs# 148
Vinayak Nagaraja
Safety and efficacy of esophageal stents preceding or during neoadjuvant chemotherapy for esophageal cancer: A
systematic review and meta-analysis abs# 149
Dannie Zarate
Colorectal cancer surgery rates in indigenous versus nonindigenous patients abs# 150
Posters - Basic and Translational
Masoomeh Bakhshayesh
Inducible apoptosis role of TGF- β1 associated with SMAD-dependent on Bcl-2 expression abs# 161
Kylie Cheng
Psychosocial Distress Screening in Oncology: A Qualitative Study of Health Professionals. abs# 162
Barbara Page
Lung Cancer in Rural and Remote Aboriginal and Torres Strait Islander Communities in Queensland abs# 163
Barbara Page
An Audit and Evaluation of the Lung Cancer Journey: Metropolitan and Non - Metropolitan abs# 164
Ka Hi (May) Mak
Compliance with nutrition prescription in patients with Head and Neck Cancer undergoing radiotherapy: a descriptive
study abs# 165
Posters - Clinical research
Vanessa Beesley
Prevalence, risk factors and risk estimates for lower limb lymphoedema and lymphoedema-specific supportive care
needs in women diagnosed with endometrial cancer abs# 166
Alison Buete
DENOSUMAB induced Hypocalcaemia in Advanced cancers at the Top End; Severity and Management abs# 167
Kevin Chin
Long-Term Survival in Patients with Metastatic Melanoma who Received Ipilimumab in Four Phase II Trials abs# 168
Kevin Chin
Survival Analysis with 5 years of Follow-Up in a Phase III Study of Ipilimumab and Dacarbazine in Metastatic Melanoma
abs# 169
Katie De-loyde
RCT of Colonic Stent Insertion vs. Surgical Decompression for Patients with Malignant Incurable Large Bowel
Obstruction abs# 170
Belinda Fazekas
Monitoring clinical studies – improving quality abs# 171
Tina Griffiths
Evaluation of an Education Program to Facilitate Patient Adherence, Toxicity Monitoring and Promote Safety and
Wellbeing in the Self Administration of Oral Chemotherapy in the Home Setting abs# 172
Catherine Han
A Drug-Interaction Study of Effects of Calcium and Magnesium Infusions on Oxaliplatin Pharmacokinetics, Motor
Nerve Hyperexcitability and Acute Neurotoxicity Symptoms in Colorectal Cancer Patients abs# 173
Michelle Hong
Retrospective Review of Hypersensitivity Reactions to Paclitaxel with Oral Versus Intravenous Dexamethasone,
Antihistamine and H2-Antagonist Premedication. abs# 174
Abdel Nasser Hosein
Granulocytic Sarcoma of the Bladder as the Sole Manifestation of Acute Myelogenous Leukemia: a case report and
literature review abs# 175
Chi-Yin Kao
Development of Guidelines to Inform the Content of Summarized Patient Information Forms (SPIFs) Regarding CancerRelated, Clinical Trials abs# 176
David Lau
Survival of Patients with Resected Cerebral Metastases from Gastrointestinal Cancers abs# 177
Sharon Lawn
A Pilot Study of a Healthy Lifestyle Self-Management Intervention with Cancer Survivors abs# 178
Jaein Lee
Late Effects of Oxaliplatin-induced peripheral Neuropathy (LEON) abs# 179
Yeh Chen Lee
CHARM Utility study abs# 180
Bill Loukas
Monitoring and treatment of hypomagnesaemia in patients receiving cetuximab abs# 181
Tracy Michener
Ipilimumab Retreatment Following Induction Therapy: The Expanded Access Program (EAP) Experience abs# 182
Jessica Miller
A Prospective Study of Anti-Mullerian Hormone (AMH) As a Potential Predictor of Chemotherapy-Induced
Menopause: Preliminary Results. abs# 183
Gillian Mitchell
An introduction to ICCon - Inherited Cancer Connect Partnership abs# 184
David Mizrahi
Physical Activity (PA) Participation for Women with Ovarian Cancer abs# 185
Vinayak Nagaraja
Factors Predictive of Tumor-Positive Nonsentinel Lymph Nodes after Positive Sentinel Lymph Node Biopsy in
Melanoma Patients: Westmead Melanoma Unit Experience and a Review of Literature abs# 186
Brent O'Carrigan
Metastatic central nervous system recurrence in breast cancer: Impact of tumour sub-type abs# 187
Kevin O'Shaughnessy
The Prostate Cancer Journey: Results of an Online Survey of Men and their Partners. abs# 188
Kevin O'Shaughnessy
Impaired Sexual Function and Prostate Cancer; A Mixed Method Investigation into the Experiences of Men and their
Partners abs# 189
Lovelace Osei-Tutu
Audit of Patient Selection and Protocols for Prostate Cancer Active Surveillance in South Australia abs# 190
Sunita Padman
Qualitative Results of the LEON study: Late Effects of Oxaliplatin-Induced Peripheral Neuropathy abs# 191
Ganesalingam Pranavan
Incidence of gastrointestinal toxicity with capecitabine monotherapy in metastatic breast and metastatic colorectal
cancer patients abs# 192
Carolina Sandler
Barriers to Recruitment for a Post-Cancer Fatigue Intervention Study - The TOPS Trial. abs# 193
Jingli Song
Effectiveness and safety of first-line ipilimumab (IPI) 3mg/kg therapy for advanced melanoma (AM): Evidence from a
U.S. multisite retrospective chart review abs# 194
Richard De Boer
Hypocalcaemia in patients with metastatic bone disease (MBD) receiving denosumab abs# 195
David Chan
Meta-Analysis of Progression-Free Survival Impact of Biological Therapy in Relapsed Metastatic Colorectal Cancer abs#
196
Posters – Education
Belinda Fazekas
Audit Versus Actual Recruitment in Palliative Care Clinical Trials abs# 197
Paul Katris
Communication between Health Professionals and Cancer Patients about Integrative, Complementary and Alternative
Therapies: Exploring Different Perspectives abs# 198
Paul Katris
Current Australian Research Activity Investigating Complementary and Integrative Therapies in Oncology: A Survey of
COSA Members abs# 199
Ben Stevenson
Complementary and Alternative Medicines Use by Cancer Patients and the Role of the Drug Information Pharmacist.
abs# 200
Josephine Thomas
Student Perceptions of a Consumer Led Discussion Group Format to Improve Awareness of the Patient Perspective
abs# 201
Elise Watson
A Randomised Controlled Trial to assess the impact of a cognitive dissonance intervention to alter attitudes and
intentions to tan among young adults in Australia. abs# 202
Posters - Health services
Marliese Alexander
Inpatient Chemotherapy Service Improvement Project abs# 203
Marliese Alexander
Quit Or Quiet? High Smoking Prevalence, Low Disclosure Rates and Low Smoking Cessation Program Participation
Rates among Cancer Patients abs# 204
Pawan Bajaj
Palliative Car Referrals and Time Period between Last Chemotherapy and Death in Metastatic Breast Cancer Patients
in North Queensland. abs# 205
Lisa Beatty
Cancer Coping Online: Findings and lessons learned from a phase II RCT of an eHealth program for reducing cancerdistress. abs# 206
Paul Katris
COSA Position Statement - The Use of Complementary and Alternative Medicine by Cancer Patients abs# 210
Alison Buete
Analysis of Pharmacist role in Haematology and Oncology at Royal Darwin Hospital abs# 211
Michael Cooney
Identifying and addressing the supportive care needs of the ‘complex’ patient with Multiple Myeloma within a Nurse
Practitioner led service abs# 212
Jessica Delaney
Victorian Patient Management Framework: Achievements and future directions abs# 213
Brett Doble
Navigating Indirect Utility Models in Cancer: Mapping the EORTC QLQ-C30 onto the EQ-5D abs# 214
Brett Doble
Assessing the Value of Precision Therapies in the Multi-Omics Era of Medicine abs# 215
Mathew George
Community Oncology: Patients’ perspective on a rural Australian medical oncology outreach service abs# 216
Afaf Girgis
Feasibility study of an oncology nurse practitioner model of care in a rural cancer setting abs# 217
Livia Haddow
Service Mapping the Flow of Care for Chemotherapy Outpatients at Sir Charles Gairdner Hospital abs# 218
Carole Harris
Do Pharmaceutical Claims Accurately Reflect Oncology Prescribing Practice: Evidence from an Australian HER2+ Early
Breast Cancer Cohort (HER2EBC) abs# 219
Angela Ives
Development and implementation of a clinical cancer data collection system in WA abs# 220
Claire Johnson
How acceptable and beneficial do clinicians think peer review of multidisciplinary cancer teams is? abs# 221
Anna Kemp
Women commencing anastrozole, letrozole or tamoxifen for early breast cancer: the impact of comorbidity and
demographics on choice. abs# 222
Daniel McKavanagh
Is the chemo ready yet?! Gaining efficiency in parenteral cancer chemotherapy supply at a large tertiary level hospital
abs# 223
Jordana McLoone
Where to care for childhood cancer survivors? Survivor and oncology service provider perspectives
224
abs#
Nur Hayati Mohd Alias
Radiotherapy access in the West Hume region: any need for a local radiation facility? abs# 225
Danielle Muscat
Risk perception in medical imaging: Understanding the effect of two risk presentation formats on knowledge abs# 226
Vinayak Nagaraja
Forthcoming Prognostic Markers for Oesophageal Cancer: A Systematic Review and Meta-Analysis abs# 227
Cat Parker
An exploration of the relationship between funding and patient accrual to oncology clinical trials: Additional Funding
Intervention Trial (AFIT) abs# 228
Cat Parker
An Estimate of the Rate of Participation by Adolescent and Young Adults (AYA) in Oncology Clinical Trials in Victoria:
2011 and 2012 abs# 229
Cat Parker
Celebrating 25 years of the Clinical Trials Management Scheme (CTMS): Victorian clinical trial activity, 1988-2013 abs#
230
Jane Phillips
Mapping cancer pain screening, assessment and reassessment practices within one Australian health district: results
from a baseline chart audit abs# 231
Jane Phillips
Exploring opiate errors in the specialist cancer and palliative care setting: perceptions of key stakeholders abs# 232
Jesmin Shafiq
An Evidence-Based Estimation of Local Control and Survival Benefit of Radiotherapy for Colorectal Cancer abs# 233
Neli Slavova-Azmanova
Peer Review of Multidisciplinary cancer teams: a pilot study abs# 234
Carmel Vermeltfoort
It’s Not Just a Numbers Thing – Looking for Quality in MDMs abs# 235
Eswaran Waran
Indigenous Patients with Metastatic Lung Cancer at the Royal Darwin Hospital: An Eleven Year Audit of Data Regarding
Chemotherapy, Radiotherapy and Palliative Care. abs# 236
Rachel Whiffen
Combining Efforts in Advocating for Cancer Care Coordinators (a Victorian perspective) abs# 237
Victoria White
Assessing cancer patients experiences of care: the Victorian experience. abs# 238
Chris Packer
Development of a capability framework to support the provision of chemotherapy within a shared care model for
children and adolescents with cancer abs# 239
Bridget Wislang
Working Together: An Integrated Model of Care for Cancer Services abs# 240
Patsy Yates
The Challenges in Integrating Care Coordinators into Cancer Care – an Analysis of Australian Evaluation Data abs# 241
Sally Yeo
Does the Availability of a Local Service Change the Types of Patients Who Accesses Radiotherapy? An Investigation in
the Western NSW Local Health District (WNSWLHD). abs# 242
Elvira Zilliacus
Working with patients from culturally and linguistically diverse backgrounds: Perspectives of oncology health
professionals. abs# 243
Session 2 - Wednesday
Best of the Best Posters
Phyllis Butow
Caring for women with ovarian cancer in the last year of their life: Impact on the caregiver abs# 151
Laal Farrokhzadi
Physical activity predictors and preferences among gynaecological cancer survivors abs# 152
Heather Lane
How are geriatric assessment domains and age discussed in cancer multidisciplinary meetings? abs# 153
Janelle Levesque
Do men with prostate cancer and their partners receive the information and support they need for optimal illness selfmanagement? abs# 154
Vanessa Beesley
Pancreatic cancer patient’s moderate or high unmet supportive care needs over time and risk factors of future unmet
needs abs# 155
Joanne Bowen
Immune genetic variability is associated with risk of severe gastrointestinal toxicity in patients treated with
Fluorouraci abs# 156
Heather Heron-Speirs
Understanding the distress and coping of men with cancer indicates the integration of comprehensive and accessible
information into standard treatment paths abs# 157
Victoria-Mae Rasmussen
Stress and burnout, work engagement and meaningful work in psychosocial health professionals working in oncology
abs# 158
Patricia Valery
Traditional Indigenous medicine and complementary medicine use amongst Indigenous cancer patients in
Queensland, Australia abs# 159
Posters – Epidemiology
Kate Christian
Join a Research Study Data Base abs# 251
Laal Farrokhzadi
Identification and predictors of physical activity barriers among gynaecological cancer survivors, and association with
physical activity levels abs# 252
Eleonora Feletto
Changes in Cancer Mortality and Incidence in Australia 1987-2007 abs# 253
Amanda Goldrick
Retrospective Study of Febrile Neutropenia and G-CSF use in Australian Women Receiving Docetaxel plus
Cyclophosphamide (TC) as Adjuvant Therapy for Early-Stage Breast Cancer (ESBC) abs# 254
Jesse Gould
Understanding factors in emergency presentation for colorectal cancer surgery abs# 255
Chris Hocking
Indigenous Patients and Metastatic Colorectal Cancer: Results from the South Australian (SA) Metastatic Colorectal
Cancer (mCRC) Registry abs# 256
Kate McBride
Research Participants’ Views of the Feedback of Genetic Test Information Following Participation in the International
Sarcoma Kindred Study (ISKS) abs# 257
Katherine Simons
Management of malignant spinal cord compression across north-eastern Melbourne abs# 258
Sharon Pattison
Predictors of outcome after surgery for gastric cancer in a Western cohort abs# 259
Zumin Shi
Prostate-Specific Antigen (PSA) Rate of Decline Post External Beam Radiotherapy Predicts Prostate Cancer Death abs#
260
Visalini Nair-Shalliker
The New South Wales Cancer, Lifestyle and Evaluation of Risk Study (CLEAR): A resource for cancer research. abs# 261
Matthew Soeberg
Australian data in global surveillance of population-based cancer survival (the CONCORD programme) abs# 262
Claire Vajdic
Survival after Cutaneous Melanoma in Kidney Transplant Recipients: A Population-Based Matched Cohort Study abs#
263
Elizabeth Varughese
Awareness of General and Personal Risk Factors for Uterine Cancer Among Healthy Women - A Rural Australian Study
abs# 264
Dannie Zarate
The Effect of the Ageing Population on the Distribution of Cancers abs# 265
Posters - Supportive care
Zia Ansari
Psychosocial Analysis of Cancer Survivors in Rural NSW, Australia abs# 266
Vicki Barrington
Food Plate Waste, Dietary Intake and Malnutrition in an Inpatient Oncology Setting abs# 267
Amelia Beaumont
Engagement with online cancer support and information platforms in Australia abs# 268
Anne Booms
Introducing the Nurse Practitioner Role to Improve Regional Oncology Patient Outcomes abs# 269
Fran Boyle
First Australian Study of Scalp Cooling with the Dignitana Dignicap™ for Prevention of Alopecia induced by
Docetaxel/Cyclophosphamide Chemotherapy in Women with Early Breast Cancer abs# 270
Lisa Brady
Improving Practice: Implementation and Evaluation of an Elearning Program for Health Care Professionals in
Supportive Care of Cancer Patients at Peninsula Health abs# 271
Sally Brooks
Development and Introduction of Guidelines Regarding the Co-Administration of Azole Antifungal Agents and Vinca
Alkaloids abs# 272
Tabitha Frew
Lung Cancer: Predictors of Stigma among Health Professionals versus Community Members abs# 273
Priscilla Gates
Development of a Nurse-Led Survivorship Intervention for Long-Term Survivors of Hodgkin Lymphoma. abs# 274
Jane Harrowfield
Long terms outcomes of a Head and Neck Cancer Dietitian-Led Clinic (DLC) abs# 275
Jane Harrowfield
An Evidence-Based Nutrition Care Pathway for Surgical Head and Neck Patients abs# 276
Ben Huntingdon
The Impact of Providing Peer Support within a Research Context: A Qualitative Insight into Delivering a Combined
Nurse-Peer Psychosocial Intervention for Gynaecological Cancer Patients abs# 277
Marcellinus Kim
“There are No Good Things about having a PEG tube, Except it Keeps me Alive”. Nutritional Status and Quality of Life
in Long Term Home Enteral Nutrition Post Treatment Head and Neck Cancer Patients. abs# 278
Sue Sinclair
Stigma and nihilism in lung cancer within the Australian context abs# 279
Bogda Koczwara
A Pilot Study of Tailored Nutrition and Physical Activity Intervention in Cancer Survivors abs# 280
Eng-Siew Koh
A Longitudinal Psychosocial Distress Assessment in Malignant Glioma Patients and their Carers: A Comparative Study
abs# 281
Alastair Kwok
Reasons for dietary change and information and support needs in women who gain weight following chemotherapy
for breast cancer abs# 282
Donna Lever
Pioneering Survivorship – Providing Care to Patients of Regional and Rural South-West Victoria. abs# 283
Elizabeth Maunsell
Validating the Content of a Brief Informational Intervention to Empower Patients and Spouses Facing Breast Cancer:
Perspectives of Both Couple Members abs# 284
Kelsey Moore
"I have quality of life...but..." Exploring quality of life and support needs in head and neck cancer: An application of the
Transactional Model of Stress Appraisal and Coping. abs# 285
Hunter Mulcare
The tip of the iceberg - which patients attend the oncology psychologist? abs# 286
Andrew Murnane
Effects of a Structured Exercise Program on Pre-Operative Optimisation Prior to Major Cancer Sugery abs# 287
Anna Piggin
Outcomes of Haematology/Oncology Patients Admitted to Intensive Care Unit (ICU) at The Canberra Hospital (TCH)
abs# 288
Amy Prawira
Patterns of Palliative Care Involvement in Metastatic Non-Small Cell Lung Cancer Patients: Limitations to Early
Palliative Care in a Rural Australian Centre. abs# 289
Fiona Runacres
Restorative Care for Advanced Cancer Patients: A Retrospective Clinical Audit of Outcomes for Patients Admitted to
An Inpatient Palliative Care Unit abs# 290
Mariana Sousa
Qualitative Analysis of Knowledge, Attitudes and Experiences Regarding Urinary Symptoms among Postmenopausal
Women Taking Aromatase Inhibitors for Early Stage Breast Cancer abs# 291
Cindy Tan
Prevalence of complementary and alternative diet therapies used in patients attending oncology and haematology day
units at a teaching hospital abs# 292
Natalie VanderHaak
Perceived Nutritional needs of Adolescents and Young Adults with Cancer: A Survey of Dietitians and Patients abs#
293
Natalie VanderHaak
A Retrospective Audit of the Nutritional Status and Management of Adolescents and Young Adults (AYAS) with Cancer
During and after Treatment abs# 294
Aditi Vedi
Timely Management of Febrile Neutropenia in Children with Cancer abs# 295
Aditi Vedi
Oral vs. Intravenous Antibiotics in Treatment of Paediatric Febrile Neutropenia abs# 296
Alyssa White
Consumer-led design of patient resources: a qualitative study of cancer resources abs# 297
Samantha Wieringa
Dose escalation of irinotecan in a patient taking rifampicin. abs# 298
Samantha Wieringa
Vemurafenib – can it be crushed or chewed? abs# 299
Lisa Brady
Putting supportive care on the map: The development of a supportive care multidisciplinary team meeting for cancer
patients in the ambulatory setting abs# 300
Posters – Gastro-intestinal cancers
Bibek Acharya
A Single Institution's Experience in Rectal Cancer abs# 301
Manoj Behera
Role of Neoadjuvant Chemoradiation in Locally Advanced Carcinoma Rectum: A Tertiary Cancer Centre Study. abs#
302
Elizabeth Burmeister
Pancreatic Cancer Quality Care - Is there Consensus Amongst Clinicians? abs# 303
Prue Cormie
Exercise as medicine in the management of pancreatic cancer: a case study abs# 305
Viet Do
An Estimation of the Population Survival Benefit of First-line Chemotherapy for Upper Gastrointestinal Cancer abs#
306
Donna Gillies
Identifying Shortcomings and Variation in the Diagnosis of Colorectal Cancer Patients abs# 307
Yada Kanjanapan
Retrospective analysis of resected gastrointestinal stromal tumours (GISTs) comparing existing risk stratification
models and assessing the influence of GIST genotypes on recurrence and mortality abs# 308
Peey-Sei Kok
A Clinical Audit of Anal Cancer in a Single Tertiary Centre Over 10 Years abs# 309
Daniel McKavanagh
Cetuximab use in metastatic colorectal cancer at Princess Alexandra Hospital: streamlined analysis using electronic
medical record data abs# 310
Dmytro Osynskyi
Disseminated Tumour Cells (Dtcs) in Bone Marrow (BM) of Gastric Cancer Patients with M0 Category: Correlation with
Tumour Hypoxia and Clinical Relevance abs# 311
Amy Scott
Is Second Line Chemotherapy in Pancreatic Cancer One Line Too Many? abs# 312
Mary-Anne Young
“Life Changing” The Lived Experience of Risk Reducing Gastrectomy in People at Risk of Hereditary Diffuse Gastric
Cancer. abs# 313
Posters - Geriatric oncology
Bianca Devitt
Can Older Patients use an Electronic Tablet to Complete a Cancer Specific Geriatric Assessment? Results of a Pilot
Study. abs# 314
Ada Hon
Polypharmacy in the geriatric oncology setting- multidisciplinary mayhem abs# 315
Amy ( Hsin-Chieh ) Hsieh
The role of Comprehensive Geriatric Assessment in management of metastatic prostate cancer: A two centres
‘experience’ abs# 316
Sudhakar Reddy Vemula
Descriptive Analysis of use of Pemetrexed in Elderly NSCLC Patients – Institutional Experience at Calvary Mater
Hospital, Newcastle. Dr. Sudhakar Reddy Vemula, Dr. Ina IC Nordman. abs# 317
Annie Wong
Assessing Toxicity Risk in Senior Chemotherapy patients (AT RISC) – a prospective audit abs# 318
Posters - Service provision
Anne Booms
Evaluating the Oncology Nurse Practitioner Role: Success or Failure? abs# 319
Vicki Durston
Brightways - A Cabrini Breast Cancer Service abs# 320
Heather Jordan
Development of a Nutrition Care Pathway to Improve Service Provision for Patients with an Upper Gastrointestinal
Malignancy abs# 321
Peter Lau
Chemotherapy Infusion Preference Survey (CHIPS): Patient Preferences for Chemotherapy Scheduling abs# 322
Belinda Morris
Simplifying complexity: Cancer Pharmacy Services for Chemotherapy Units in Rural South Australia abs# 323
Christine Scott
Establishing Oncology Massage as Part of a Wellness Program in a Comprehensive Cancer Centre abs# 324
Marilyn Wendt
Treatment Standards Development - A Work In Progress abs# 325
Colleen Berryman
Leveraging Technology to Strengthening the Delivery of Multidisciplinary Care: SMICS’ Multidisciplinary Team (MDT)
Meeting Room Upgrade Project abs# 326
Robyn Wilson
Bringing Healthcare Home: a patient centred approach to cancer care abs# 327
Posters - Trials in progress
Eva Segelov
ICECREAM: Irinotecan Cetuximab Evaluation and the Cetuximab Response Evaluation Among Patients with G13D
Mutation abs# 328
Andrew Spillane
We Need a Trial to Evaluate Whether Patients with Involved Inguinal Lymph Nodes Should Have Inguinal or IlioInguinal Lymphadenectomy; an Overview of the Proposed Trial ANZMTG 01.12 EAGLE FM Protocol abs# 329
Janette Vardy
The CHALLENGE Trial. A Phase III Study of the Impact of a Physical Activity Program on Disease-Free Survival in Patient
with High Risk Stage II or Stage III Colon Cancer: A Randomised Controlled Trial abs# 330
Haryana Dhillon
Efficacy and safety of Ginkgo biloba for cognitive function and fatigue in breast cancer patients undergoing adjuvant
chemotherapy: A randomised, controlled trial abs# 331
Haryana Dhillon
Cognitive Rehabilitation for Breast Cancer Survivors with Perceived Cognitive Impairment abs# 332
Ivana Durcinoska
NSW Bowel Cancer Care Survey: Population-based assessment of patients cancer care coordination needs and
preferences abs# 333
Gerald Fogarty
Accrual to a Randomised Trial of Whole Brain Radiotherapy in Melanoma Brain Metastases is Feasible. abs# 334
Jason Fowler
Health Related Quality of Life in Mesothelioma abs# 335
Victoria Gray
Can a Complex Intervention Targeted at the Community and at Health Care Providers Reduce the Total Diagnostic
Interval for Common Cancers in Rural WA? abs# 336
Pascale Guitera
ANZMTG 02.12: A Phase III Trial of Imiquimod Topical Treatment Versus Radiotherapy abs# 337
Trish Livingston
Efficacy and Cost-Effectiveness of a Telephone Outcall Program to Reduce Carer Burden and Depression Among Carers
of Cancer Patients [PROTECT]. Rationale and Design of a Multi-State, Multi-Centre Randomised Controlled Trial abs#
338
Zebunnessa Rahman
The Impact of Seizures on Cognition and Health Related Quality of Life in Primary Brain Tumours. abs# 339
`